MedTrace Logo

Registry Platform Colorectal Cancer

NCT04867525 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-05-01

No results posted yet for this study

Summary

The registry aims to collect and analyse information on the antineoplastic treatment of patients with metastatic colorectal cancer, treated in palliative intention in daily routine practice in Germany.

Conditions

  • Colorectal Cancer Metastatic

Interventions

OTHER

Physician's choice according to patient's needs.

Routine care as per site standard.

Sponsors & Collaborators

  • iOMEDICO AG

    lead INDUSTRY

Principal Investigators

  • Nicolas Graf, PD Dr. · Deggendorf Institute of Technology, Faculty of Applied Healthcare Sciences

  • Frank Kullmann, Prof. Dr. · Weiden i.d.O.

  • Marlies Michl, PD Dr. · München

  • Jens Neumann, Prof. Dr. · München

  • Roland Schnell, PD Dr. · Frechen

  • Sebastian Stintzing, Prof. Dr. · Berlin

  • Karin Potthoff, Dr. · Freiburg i. Br.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-01
Primary Completion
2022-04-04
Completion
2026-04-30

Countries

  • Germany

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04867525 on ClinicalTrials.gov